Am I eligible?

You may be eligible if you are:

  • A resident of the United States
  • A pregnant woman diagnosed with migraine who has:
    • Taken Nurtec ODT (rimegepant) during pregnancy or just prior to pregnancy (within 3 days prior to conception)
    • Taken other migraine medications during pregnancy or just prior to pregnancy*
    • Not taken any migraine medications during pregnancy

*Please note: If you have taken certain migraine medications (e.g., Reyvow®, Ubrelvy®, Aimovig®, Ajovy®, Emgality®, Qulipta™, or Vyepti®) prior to or during pregnancy you may not be eligible to participate. The registry staff can help determine your eligibility if you have taken these medications.

Contact request form

Complete this form and a registry team member will contact you with more information about participating in the Registry.

I authorize the MONITOR Pregnancy Registry to contact me and/or leave a message for me at these numbers or to contact me via email at the address listed below. I agree to the Registry referencing the MONITOR Pregnancy Registry in messages or emails.

The registry is open from 8:30 am – 5:00 pm ET Monday-Friday

Privacy Statement:

Pharmaceutical Product Development, LLC. (PPD) respects your privacy and understands that it is important to you. The information you provide on this form will be used to contact you for the purposes of assessing your eligibility to participate in the MONITOR Pregnancy Registry. This information will be held by PPD and not shared with the study sponsor (Biohaven Pharmaceuticals, Inc.) or any other third party without your permission. In the event you choose not to enroll, Registry staff will request permission to share your contact information with PPD (a Pharmacovigilance vendor hired by Biohaven Pharmaceuticals, Inc). in order for them to contact you for safety follow up about your pregnancy. If you do not provide permission, and do not enroll in the Registry your contact details will be deleted.